An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

NCT02925494 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

433

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Fibroids
Heavy Menstrual Bleeding

Interventions

DRUG: Estradiol/Norethindrone Acetate
DRUG: Elagolix

Sponsor

AbbVie